Letter: infliximab therapy for patients with inflammatory bowel disease – some unanswered questions. Authors’ reply

Publisher: John Wiley & Sons Inc

E-ISSN: 1365-2036|42|9|1134-1134

ISSN: 0269-2813

Source: ALIMENTARY PHARMACOLOGY & THERAPEUTICS, Vol.42, Iss.9, 2015-11, pp. : 1134-1134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract